A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
A gene, ATM , that is mutated in the autosomal recessive disorder ataxia telangiectasia (AT) was identified by positional cloning on chromosome 11q22-23. AT is characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, cancer predisposition, radiation sensitivity, and cell cycle abnormalities. The disease is genetically heterogeneous, with four complementation groups that have been suspected to represent different genes. ATM , which has a transcript of 12 kilobases, was found to be mutated in AT patients from all complementation groups, indicating that it is probably the sole gene responsible for this disorder. A partial ATM complementary DNA clone of 5.9 kilobases encoded a putative protein that is similar to several yeast and mammalian phosphatidylinositol-3′ kinases that are involved in mitogenic signal transduction, meiotic recombination, and cell cycle control. The discovery of ATM should enhance understanding of AT and related syndromes and may allow the identification of AT heterozygotes, who are at increased risk of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [49]
Citations
Cites
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,391
A workbench for multiple alignment construction and analysis
Schuler, G. D., Altschul, S. F., & Lipman, D. J. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340090304 · Cited by 985
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 834
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789
Phosphatidylinositol 3-Kinase Encoded by Yeast VPS 34 Gene Essential for Protein Sorting
Schu, P. V., Takegawa, K., Fry, M. J., Stack, J. H., Waterfield, M. D., & Emr, S. D. (1993) · Science · doi:10.1126/science.8385367 · Cited by 778
Research works printed but not linked: 12
- Green, M. H. L., Journal of Cell Science 6: 127 (1987).
- Lange, E., American Journal of Human Genetics 57: 112 (1995).
- Lavin, M. F., Ataxia-Telangiectasia: 235 (1993).
- MCCONVILLE, C.M., GENETIC AND PHYSICAL MAPPING OF THE ATAXIA-TELANGIECTASIA LOCUS ON CHROMOSOME 11Q22-Q23, INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 66: S45 (1994).
- Meyn, M. S., American Journal of Human Genetics 55 Suppl.: A3 (1994).
- OSKATO, R, AMERICAN JOURNAL OF HUMAN GENETICS 53: A1055 (1993).
- Sedgwick, R. P., Handbook of Clinical Neurology 16: 347 (1991).
- Shiloh, Y., American Journal of Human Genetics 55 Suppl.: A49 (1994).
- Shiloh, Y., Ataxia-Telangiectasia: Genetics Neuropathology and Immunology of a Degenerative Disease of Childhood: 111 (1985).
- Shiloh Y. European Journal of Human Genetics in press.
- Uhrhammer, N., American Journal of Human Genetics 57: 103 (1995).
- ZAMPETTIBOSSELE.F, INT J RADIAT BIOL 39: 547 (1981).
Cited by
Items 901–1,000 of 1,009
Alterman, N., Fattal‐Valevski, A., Moyal, L., Crawford, T. O., Lederman, H. M., Ziv, Y., & Shiloh, Y. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31853 · Cited by 63
“A-T is caused by mutations in the ATM gene [Savitsky et al., 1995a,b], which encodes the nuclear protein kinase ATM, the chief activator of the cellular This article contains supplementary material, which may be viewed at the American Journal of Medical Genetics website at http://www.…”
BackgroundSelf-citationATM dependent apoptosis in the nervous system
Lee, Y., & McKinnon, P. J. (2000) · APOPTOSIS · doi:10.1023/a:1009637512917 · Cited by 61
Future Research Directions for Evaluating Human Genetic and Cancer Risk from Environmental Exposures
Albertini, R. J., Nicklas, J. A., & O’Neill, J. P. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s3503 · Cited by 72
Checkpoints Take the Next Step
Carr, A. M. (1996) · Science · doi:10.1126/science.271.5247.314 · Cited by 54
Proteolysis and the biochemistry of life-or-death decisions.
Ashkenas, J., & Werb, Z. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.1947 · Cited by 57
“ATM, a major regulator of p53, may induce p53 by an indirect mechanism, p53-dependent cycle checkpoint control is then mediated through induction of transcription of p21, which inhibits the cyclin-cdk complex, and Gadd 45, which binds to PCNA. p53 activation is also central to induction ofapoptosis (botwm).”
BackgroundInfluentialDNA Repair Mechanisms, Protein Interactions and Therapeutic Targeting of the MRN Complex
McCarthy, C. E., Darwiche, F., & Tainsky, M. A. (2022) · Cancers · doi:10.3390/cancers14215278 · Cited by 67
ATM polymorphisms and risk of lung cancer among never smokers
Lo, Y.-L., Hsiao, C., Jou, Y., Chang, G., Tsai, Y., Su, W., Chen, Y., Huang, M., Chen, H., Yang, P., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.007 · Cited by 55
Russo, I., Cosentino, C., Giudice, E. D., Broccoletti, T., Amorosi, S., Cirillo, E., Aloj, G., Fusco, A., Costanzo, V., & Pignata, C. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02600.x · Cited by 56
“These observations point to additional roles for ATM in cellular metabolism other than its direct role in the response to DSBs induction, such as its involvement in ROS balance.”
BackgroundInfluentialOffer, S. M., Pan‐Hammarström, Q., Hammarström, L. L. G., & Harris, R. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012260 · Cited by 55
“Varying degrees of antibody deficiency have also been noted in chromosomal instability syndromes such as ataxiatelangiectasia (A-T, ATM mutations), Nijmegen breakage syndrome (NBS, NBS1 mutations), and ataxia-telangiectasia-like disorder (ATLD, MRE11 mutations) [24–30].”
Sankunny, M., Parikh, R. A., Lewis, D. W., Gooding, W. E., Saunders, W. S., & Gollin, S. M. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22125 · Cited by 59
Shahrabani-Gargir, L., Pandita, T. K., & Werner, H. (2004) · Endocrinology · doi:10.1210/en.2004-0613 · Cited by 60
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer:
Launonen, V., Mannermaa, A., Stenbäck, F., Kosma, V.-M., Puistola, U., Huusko, P., Anttila, M., Bloigu, R., Saarikoski, S., Kauppila, A., et al. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00279-x · Cited by 53
Breast carcinoma genetics from a primary care perspective
Burke, W., Press, N. A., & Pinsky, L. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3+<543::aid-cncr4>3.0.co;2-a · Cited by 3
A Review of Epstein-Barr Virus Infection in Patients with Immunodeficiency Disorders
Okano, M., & Gross, T. G. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40780-3 · Cited by 53
Eighth International Workshop on Ataxia-Telangiectasia (ATW8).
Lavin, M. F., CONCANNON, P. J., & Gatti, R. A. (1999) · PubMed · Cited by 60
Self-citationGostin, L. O. (1995) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.1995.tb01374.x · Cited by 53
Multiple Signaling Pathways Involving ATM
Kastan, M., Lim, D., KIM, S.-T., Xu, B., & Canman, C. E. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.521 · Cited by 60
Lloret, A., & Beal, M. F. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02809-1 · Cited by 52
Katsel, P., Tan, W., Fam, P., Purohit, D. P., & Haroutunian, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068361 · Cited by 52
“Ataxia telangiectasia (A-T) is a human disease caused by ATM deficiency and characterized by the failure of CCL checkpoints, predisposition to cancer, immunodeficiency and by neurologic abnormalities caused by significant loss of neurons [34].”
BackgroundMovement Disorder in Ataxia-Telangiectasia
Nissenkorn, A., Hassin‐Baer, S., Lerman, S. F., Levi, Y. B., Tzadok, M., & Ben‐Zeev, B. (2012) · Journal of Child Neurology · doi:10.1177/0883073812441999 · Cited by 54
Homann, N., Tillonen, J., & Salaspuro, M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000415)86:2<169::aid-ijc4>3.0.co;2-3 · Cited by 140
Boehrs, J. K., He, J., Halaby, M., & Yang, D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04254.x · Cited by 52
“Sequences of the ATM protein include a kinase domain that is related to that of the PI 3-kinase protein family, a leucine zipper domain (a region that interacts with other proteins), and several nuclear localization signals (Savitsky et al. 1995).”
BackgroundImmunoglobulin class switch recombination deficiencies
Kracker, S., Gardës, P., Mazerolles, F., & Durandy, A. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.01.012 · Cited by 60
The human intra-S checkpoint response to UVC-induced DNA damage
Kaufmann, W. K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp230 · Cited by 52
“ATM[10], non-essential checkpoint kinase that is activated by DNA dsb and changes in chromatin Claspin[92], Chk1- and Timassociated checkpoint mediator PP2A[176], phosphatase that regulates checkpoint kinase activity”
BackgroundHuman T-Cell Leukemia Virus Type 1 Tax Attenuates the ATM-Mediated Cellular DNA Damage Response
Chandhasin, C., Ducu, R. I., Berkovich, E., Kastan, M. B., & Marriott, S. J. (2008) · Journal of Virology · doi:10.1128/jvi.02331-07 · Cited by 52
“The mechanisms by which eukaryotic cells sense DNA breaks remain to be elucidated, but one of the earliest detectable events in DNA damage sensing is the activation of the ataxia telangiectasia mutated (ATM) kinase (45).”
BackgroundRecent Advances in Hereditary Spinocerebellar Ataxias
van de Warrenburg, B. P. C., Sinke, R. J., & Kremer, B. P. H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.3.171 · Cited by 55
“Its role has been particularly well described in the very rapid response to double strand DNA breaks, initiating a large number of various protein phosphorylation pathways (82, 123).”
BackgroundATM Is Upregulated During the Mitogenic Response in Peripheral Blood Mononuclear Cells
Fukao, T., Kaneko, H., Birrell, G. W., Gatei, M. H., Tashita, H., Yoshida, T., Cross, S., Kedar, P. S., Watters, D. J., Khana, K. K., et al. (1999) · Blood · doi:10.1182/blood.v94.6.1998 · Cited by 56
“GST-p53 (1-40) and ␥-32 P ATP substrate, there was a substantial increase in ATM kinase activity, in keeping with the ATM protein response to PHA (Fig 4).”
MethodInfluentialSelf-citationMolecular basis of ataxia telangiectasia and related diseases
Ball, L. G., & Xiao, W. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00165.x · Cited by 57
Pan‐Hammarström, Q., Lähdesmäki, A., Zhao, Y., Du, L., Zhao, Z., Wen, S., Ruiz‐Pérez, V. L., Dunn‐Walters, D. K., Goodship, J. A., & Hammarström, L. L. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050595 · Cited by 62
“This kinase has been suggested to have a role in CSR, as patients with ataxia-telangiectasia (A-T), who carry mutations in ATM (7), frequently show defi ciency of serum IgA, IgG2, IgG4, and IgE (8).”
BackgroundSchulz, O., Sewell, H. F., & Shakib, F. (1998) · Molecular Pathology · doi:10.1136/mp.51.4.222 · Cited by 52
Tanaka, K., Boddy, M. N., Chen, X., McGowan, C. H., & Russell, P. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3398-3404.2001 · Cited by 57
“Other PIK-like proteins include human ATM (ataxia telangiectasia mutated), ATR (ATM and Rad3 related) and DNA-dependent protein kinase (20, 39, 43).”
BackgroundBretsky, P. M., Haiman, C. A., Gilad, S., Yahalom, J., Grossman, A., Paglin, S., Berg, D. V. D., Kolonel, L. N., Skaliter, R., & Henderson, B. E. (2003) · PubMed · Cited by 58
Self-citationYamashita, T., Nifuji, A., Furuya, K., Nabeshima, Y.-I., & Noda, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590001 · Cited by 56
Genetic Polymorphisms of Ataxia Telangiectasia Mutated and Breast Cancer Risk
Lee, K.-M., Choi, J., Park, S. K., Chung, H., Ahn, B., Yoo, K., Han, W., Noh, D., Ahn, S.-H., Kim, H., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0330 · Cited by 52
“Ataxia telangiectasia mutated (ATM) is known as a member of phosphatidylinositol 3-kinase family (1), and it directly phosphorylates p53 and interacts with many other molecules involved in homologous and nonhomologous double strand break repair as well as in cell signaling in response to a critical DNA damage (2).”
BackgroundMolecular Anatomy of the DNA Damage and Replication Checkpoints
Qin, J., & Li, L. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0139:maotdd]2.0.co;2 · Cited by 59
The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
Chen, P., Tseng, W. H.-S., & Chi, J. (2020) · Biology · doi:10.3390/biology9080187 · Cited by 59
“ATM is mutated in ataxia–telangiectasia (AT; OMIM #208900) patients from all complementation groups, indicating that it is probably the single gene responsible for AT [26].”
BackgroundHao, S., Wang, Y., Zhao, Y., Gao, W. Y., Cui, W., Li, Y., Cui, J. G., Liu, Y., Lin, L., Xu, X., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac734 · Cited by 56
Szalai, C., Füst, G., Duba, J., Kramer, J., Romics, L., Prohászka, Z., & Császár, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.46 · Cited by 54
Fay, M. J., Longo, K. A., Karathanasis, G. A., Shope, D. M., Mandernach, C. J., Leong, J. R., Hicks, A., Pherson, K., & Husain, A. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-40 · Cited by 52
“Another potential tumor suppressor gene in breast cancer that is also located on chromosome 11 q22-23 is the ATM gene, which is normally important for DNA damage cell cycle checkpoint control [27].”
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
Rainville, I. R., Hatcher, S., Rosenthal, E., Larson, K., Bernhisel, R., Meek, S. M., Gorringe, H., Mundt, E., & Manley, S. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05543-3 · Cited by 52
The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links
Renaudin, X., & Rosselli, F. (2020) · Genes · doi:10.3390/genes11050585 · Cited by 61
“ATM and ATR, whose loss of function leads to ataxia telangiectasia [91] and Seckel syndrome [92], respectively, are the two master signaling kinases activated in response to DNA DSBs (ATM) or ssDNA stretches (ATR).”
BackgroundNicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
Veenhuis, S. J. G., van Os, N. J. H., Janssen, A. J. W. M., van Gerven, M. H. J. C., Coene, K. L. M., Engelke, U. F. H., Wevers, R. A., Tinnevelt, G. H., ter Heine, R., van de Warrenburg, B. P. C., et al. (2021) · Movement Disorders · doi:10.1002/mds.28788 · Cited by 52
Gueven, N., Keating, K. E., Chen, P., Fukao, T., Khanna, K. K., Watters, D., Rodemann, P. H., & Lavin, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006190200 · Cited by 51
Self-citationMyung, K., Smith, S. N., & Kolodner, R. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407010101 · Cited by 60
Self-citationGu, Q., Wang, D., Wang, X., Peng, R., Liu, J., Jiang, T., Wang, Z., Wang, S., & Deng, H. (2004) · Radiation Research · doi:10.1667/rr3158 · Cited by 51
Connelly, M. A., Zhang, H., Kieleczawa, J., & Anderson, C. W. (1998) · Genomics · doi:10.1006/geno.1997.5076 · Cited by 57
Goldberg, E. K., Glendening, J. M., Karanjawala, Z. E., Sridhar, A., Walker, G. J., Hayward, N. K., Rice, A. J., Kurera, D., Tebha, Y., & Fountain, J. W. (2000) · The American Journal of Human Genetics · doi:10.1086/302999 · Cited by 51
“…loci, such as the genes for multiple endocrine neoplasia type 1 (MEN1; Chandrasekharappa et al. 1997) and ataxia telangiectasia (ATM; Savitsky et al. 1995), have been localized and identified on this chromosome, deletions detected in many sporadic cancers do not consistently or…”
BackgroundSiede, W., Allen, J. B., Elledge, S. J., & Friedberg, E. C. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.19.5841-5843.1996 · Cited by 50
“Recently, the AT-complementing gene was cloned and shown to encode a large polypeptide with sequence similarity to phosphatidylinositol-3 kinases (19, 20).”
BackgroundJacquemin, V., Rieunier, G., Jacob, S., Bellanger, D., d’Enghien, C. D., Laugé, A., Stoppa‐Lyonnet, D., & Stern, M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.196 · Cited by 55
“A-T disorder is due to biallelic inactivation of the ATM gene (MIMn607585)”
BackgroundNon-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
Maxwell, S. A., & Mousavi-Fard, S. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213498985 · Cited by 54
“The Atm gene product is a primary component of the DDR, which has a phosphatidylinositol-3kinase-like protein kinase that phosphorylates many proteins upon DNA damage.(132) Atm mutations have identified in hematologic malignanices.”
BackgroundGenetic Syndromes Associated with Central Nervous System Tumors
Vijapura, C. A., Aldin, E. S., Capizzano, A. A., Policeni, B. A., Satō, Y., & Moritani, T. (2016) · Radiographics · doi:10.1148/rg.2017160057 · Cited by 55
Abugable, A. A., Morris, J. L. M., Palminha, N. M., Zaksauskaite, R., Ray, S., & El‐Khamisy, S. F. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102669 · Cited by 58
Clinical potential of ATM inhibitors
Lavin, M. F., & Yeo, A. J. (2020) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2020.111695 · Cited by 56
Self-citationTelatar, M., Wang, Z., Castellvı́-Bel, S., Tai, L.-Q., Sheikhavandi, S., Regueiro, J. R., Porras, O., & Gatti, R. A. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2693 · Cited by 50
Self-citationMolecular cytogenetic analysis of B-cell chronic lymphocytic leukemia
Stilgenbauer, S., Döhner, K., Bentz, M., Lichter, P., & Döhner, H. (1998) · Annals of Hematology · doi:10.1007/s002770050373 · Cited by 50
“RDX has homology to the neurofibromatosis-type 2 gene (NF2) [97], and ATM is the gene responsible for ataxia-telangiectasia and functions as a cell-cycle checkpoint regulator [82].”
BackgroundRepair of DNA damage produced by ionizing radiation: A minireview
Leadon, S. A. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80025-7 · Cited by 50
RADIATION BIOLOGY: CONCEPTS FOR RADIATION PROTECTION
Preston, R. J. (2005) · Health Physics · doi:10.1097/00004032-200506000-00003 · Cited by 58
THE GENETIC BASIS OF BREAST CANCER AND ITS CLINICAL IMPLICATIONS
Bennett, I., Gattas, M. R., & Teh, B. T. (1999) · Australian and New Zealand Journal of Surgery · doi:10.1046/j.1440-1622.1999.01515.x · Cited by 68
The p53 Response to DNA Damage In Vivo Is Independent of DNA-Dependent Protein Kinase
Jhappan, C., Yusufzai, T. M., Anderson, S., Anver, M. R., & Merlino, G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4075-4083.2000 · Cited by 50
de la Torre, C., Pincheira, J., & López-Sáez, J. F. (2003) · PubMed · doi:10.14670/hh-18.225 · Cited by 53
6 Caught in the Act: Deducing Meiotic Function from Protein Immunolocalization
Ashley, T., & Plug, A. W. (1997) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60175-1 · Cited by 52
CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families
King, A. L., Moodie, S. J., Fraser, J., Curtis, D., Reid, E., Dearlove, A., Ellis, H. J., & Ciclitira, P. J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.51 · Cited by 56
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy
Matsumoto, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084264 · Cited by 56
Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms
Regal, J. A., Festerling, T. A., Buis, J. M., & Ferguson, D. O. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt368 · Cited by 53
Non-neoplastic diseases of the testis
Nistal, M., & Paniagua, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-01970-5.50014-2 · Cited by 61
Kim, J. W., Im, S., Kim, M. A., Cho, H. J., Lee, D. W., Lee, K., Kim, T., Han, S., Oh, D., Lee, H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28245 · Cited by 50
Interaction of 14-3-3 protein with Chk1 affects localization and checkpoint function
Dunaway, S., Liu, H., & Walworth, N. C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01570 · Cited by 58
“The founding member of this family, ATM, when mutated in humans leads to the progressive neurodegenerative disorder ataxia telangiectasia characterized by severe hypersensitivity to DNA damaging agents (Savitsky et al., 1995).”
BackgroundThe Elg1 replication factor C-like complex: a novel guardian of genome stability
Ben‐Aroya, S., & Kupiec, M. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.08.003 · Cited by 56
11q Deletions in Hematological Malignancies
Monni, O. M., & Knuutila, S. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057924 · Cited by 49
Brzoska, P. M., Chen, H., Zhu, Y., Levin, N., Disatnik, M., Mochly‐Rosen, D., Murnane, J. P., & Christman, M. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7824 · Cited by 49
Soares, H. D., Morgan, J. I., & McKinnon, P. J. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00117-1 · Cited by 49
Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update
Lavin, M. F. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00027-9 · Cited by 52
Self-citationPlugging it in: signaling circuits and the yeast cell cycle
Wittenberg, C., & Reed, S. I. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80069-x · Cited by 49
Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer
Bebb, D. G., Yu, Z., Chen, J., Telatar, M., Gelmon, K. A., Phillips, N., Gatti, R. A., & Glickman, B. W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690630 · Cited by 54
“Unfortunately, the size of the gene (150 Kb genomic, 1 cDNA, 66 exons) and the lack of mutational hot spots m screening approaches to mutation detection unwieldy to (Savitsky et al, 1995; Gilad et al, 1996).”
BackgroundSelf-citationRare germline variants in known melanoma susceptibility genes in familial melanoma
Goldstein, A. M., Xiao, Y., Sampson, J. N., Zhu, B., Rotunno, M., Bennett, H. R., Wen, Y., Jones, K. M., Vogt, A. L., Burdette, L. A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx368 · Cited by 53
Coutinho, G., Xie, J., Du, L., Brusco, A., Krainer, A. R., & Gatti, R. A. (2005) · Human Mutation · doi:10.1002/humu.20170 · Cited by 49
Self-citationChiesa, N., Barlow, C., Wynshaw-Boris, A. J., Strata, P., & Tempia, F. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00581-3 · Cited by 50
Polygenic Susceptibility to Breast Cancer: Current State-of-The-Art
Ghoussaini, M., & Pharoah, P. D. P. (2009) · Future Oncology · doi:10.2217/fon.09.29 · Cited by 58
DNA Damage-dependent and -independent Phosphorylation of the hRad9 Checkpoint Protein
St.Onge, R. P., Besley, B. D. A., Park, M., Casselman, R., & Davey, S. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105152200 · Cited by 53
Laake, K., Telatar, M., Geitvik, G. A., Hansen, R. Ø., Heiberg, A., Andresen, A. M., Gatti, R. A., & Børresen‐Dale, A. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200181 · Cited by 48
Self-citationDar, M. E., Winters, T. A., & Jorgensen, T. J. (1997) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(97)00021-9 · Cited by 48
Cancer Predisposition: Ataxia–telangiectasia at the crossroads
Jackson, S. P. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00238-7 · Cited by 53
Siede, W., Nusspaumer, G., Portillo, V., Rodríguez‐Casuriaga, R., & Friedberg, E. C. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.9.1669 · Cited by 47
Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients
García, M. E. G., Kirsch, D. G., & Reitman, Z. J. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.09.008 · Cited by 55
Telomere capping in Drosophila: dealing with chromosome ends that most resemble DNA breaks
Rong, Y. S. (2008) · Chromosoma · doi:10.1007/s00412-007-0144-2 · Cited by 49
Köcher, S., Rieckmann, T., Rohaly, G., Mansour, W. Y., Dikomey, E., Dornreiter, I., & Dahm‐Daphi, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks604 · Cited by 56
“During the 24-h observation period following irradiation with 1 Gy, 11% of WT and 40% of Artemis, cells failed to incorporate EdU and therefore did not pass through the S-phase, indicating a radiation-induced primary G1-arrest (Supplementary Figure 1B, Example (1) blue bars; at 2 Gy the respective numberswere 28 and 5…”
BackgroundMethodBartocci, C., & Denchi, E. L. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00128 · Cited by 55
“An important effector of this phenomenon is H2A ubiquitylation: the levels of uH2A at DSBs are strongly reduced upon ATM inhibition after DNA damage induction (while no effect is seen on K63-linked ubiquitin species at the same site) and this reduction correlates with a reversal of repression of transcription (Shanbha…”
BackgroundInfluentialCho, E.-A., Kim, E., Kwak, S.-J., & Juhnn, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-36 · Cited by 50
“Together with ataxia–telangiectasia and RAD3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs), the ataxia–telangiectasia mutated (ATM) protein kinase plays a central role in coordinating the cellular response to DNA damage [3-5].”
BackgroundThe cerebellar degeneration in ataxia-telangiectasia: A case for genome instability
Shiloh, Y. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102950 · Cited by 49
Self-citationElevated DNA double strand breaks and apoptosis in the CNS of scid mutant mice
Vemuri, M. C., Schiller, E., & Naegele, J. R. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400806 · Cited by 48
“More significantly, mutations of the ATM gene in humans cause a severe neurodegenerative disorder called ataxia telangiectasia.(48) In both WT and scid cerebral cortices, ATM was expressed in a pattern similar to DNA-PKcs.”
BackgroundMultiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma
M’kacher, R., Griscelli, A. B., Farace, F., Laugé, A., Plassa, L., Wittmer, E., Dossou, J., Violot, D., Deutsch, É., Bourhis, J., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206826 · Cited by 53
“ATM encodes a protein containing a phosphatidylinositol-3-kinase-like domain (Savitsky et al., 1995) related to a family of proteins involved in cell cycle control and DNA damage recognition (Lavin et al., 1995; Zakian, 1995).”
BackgroundHall, J. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.001 · Cited by 47
Alterations of the double-strand break repair gene MRE11 in cancer.
Fukuda, T., Sumiyoshi, T., Takahashi, M., Kataoka, T., Asahara, T., Inui, H., Watatani, M., Yasutomi, M., Kamada, N., & Miyagawa, K. (2001) · PubMed · Cited by 46
Telomere Loss in Somatic Cells of Drosophila Causes Cell Cycle Arrest and Apoptosis
Ahmad, K., & Golic, K. G. (1999) · Genetics · doi:10.1093/genetics/151.3.1041 · Cited by 51
Launonen, V., Stenbäck, F., Puistola, U., Bloigu, R., Huusko, P., Kytölä, S. I., Kauppila, A., & Winqvist, R. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5186 · Cited by 46
Mutations and molecular variants of the NBS1 gene in non‐Hodgkin lymphoma
Cerosaletti, K. M., Morrison, V., Sabath, D. E., Willerford, D. M., & CONCANNON, P. J. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10114 · Cited by 48
RAG-Mediated V(D)J Recombination Is Not Essential for Tumorigenesis in Atm-Deficient Mice
Petiniot, L. K., Weaver, Z., Vacchio, M., Shen, R., Wangsa, D., Barlow, C., Eckhaus, M., Steinberg, S. M., Wynshaw-Boris, A., Ried, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.3174-3177.2002 · Cited by 40
“Ataxia telangiectasia (AT) is an autosomal recessive disease caused by mutation of the ataxia telangiectasia mutated (ATM) gene (16).”
BackgroundCyclers’ kinases in cell division: from molecules to cancer therapy
Milletti, G., Colicchia, V., & Cecconi, F. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01196-z · Cited by 39
“ATM has been first discovered in a patient affected by Ataxia Telangiectasia (AT) in 1995, and was found to encode a large protein of approximately 350 kDa [83].”
BackgroundCortés, M. L., Oehmig, A., Saydam, O., Sanford, J. D., Perry, K. F., Fraefel, C., & Breakefield, X. O. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300338 · Cited by 37
Role of histone acetyltransferases MOF and Tip60 in genome stability
Mir, U. S., Bhat, A., Mushtaq, A., Pandita, S., Altaf, M., & Pandita, T. K. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103205 · Cited by 32
Metadata
- Authors
- Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., & Shiloh, Y.
- Affiliations
- Tel Aviv University (IL)
- Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
- National Institutes of Health (US)
- Sheba Medical Center (IL)
- Yale University (US)
- The University of Texas Southwestern Medical Center (US)
- University of California, Los Angeles (US)
- Sapienza University of Rome (IT)
- Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- QIMR Berghofer Medical Research Institute (AU)
- Erasmus University Rotterdam (NL)
- University of Birmingham (GB)
- University of Sussex (GB)
- ORCID
- Venue
- Science
- Published
- 1995-06-23
- Volume
- 268
- Issue
- 5218
- Pages
- 1749-1753
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159168998
- Cited by
- 2,785
- References
- 54
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 45 · 2023: 34 · 2022: 43 · 2021: 73 · 2020: 60 · 2019: 61 · 2018: 53 · 2017: 67 · 2016: 59 · 2015: 69 · 2014: 80 · 2013: 75 · 2012: 87
- FWCI
- 70.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hg000882-02)
- National Human Genome Research Institute (HG00882)
- National Institute of Neurological Disorders and Stroke (R01NS031763, NS 31763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- ataxia telangiectasia, ATM gene, phosphatidylinositol 3-kinase, positional cloning, complementation groups, cerebellar degeneration, immunodeficiency, chromosomal instability, cancer susceptibility, radiosensitivity, cell cycle regulation, mitogenic signaling, meiotic recombination
- MeSH terms
- Amino Acid Sequence, Ataxia Telangiectasia, Cell Cycle, Chromosome Mapping, Chromosomes, Human, Pair 11, Cloning, Molecular, DNA-Binding Proteins, Female, Genetic Complementation Test, Heterozygote, Humans, Male, Meiosis, Molecular Sequence Data, Neoplasms, Nucleic Acid Hybridization, Proteins, Radiation Tolerance, Signal Transduction, Protein Serine-Threonine Kinases, Sequence Deletion, Phosphotransferases (Alcohol Group Acceptor), DNA, Complementary, Chromosomes, Artificial, Yeast, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.